PRQR Stock Analysis: Buy, Sell, or Hold?
PRQR - ProQR Therapeutics N.V. Ordinary Shares
$1.79
0.07 (4.39%)
▲
5d:
+30.29%
30d:
+5.62%
90d:
-10.3%
BUY
HIGH Confidence
Analysis Updated: Apr 6, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
PRQR is down 5.0% this week, but smart money is accumulating calls. Top strike: $2.5 2026-04-17 with 2,811 OI. Call ratio: 100% View Scanner →
Strength: 7.5/10
Get Alerted When PRQR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PRQR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: PRQR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: PRQR is currently trading at $1.78, which is considered slightly high relative to its 30-day fair value range of $1.53 to $1.78.
Technical Outlook: Technically, PRQR is in a strong downtrend. Immediate support is located at $1.35, while resistance sits at $1.86. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: PRQR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.88 (+419.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PRQR is in a strong downtrend. Immediate support is located at $1.35, while resistance sits at $1.86. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: PRQR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.88 (+419.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$1.53 -
$1.78
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 419.0% below Wall St target ($8.88)
Fair Price Analysis
30-Day Fair Range
$1.53 -
$1.78
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.35
Resistance Level
$1.86
Current Trend
Strong Downtrend
Technical data as of
Apr 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.43
Wall Street Target
$8.88
(+419.0%)
Revenue Growth (YoY)
6.1%
Profit Margin
-258.0%
Share & Embed Analysis
Last updated: April 06, 2026 1:52 PM ET
Data refreshes hourly during market hours. Next update: 2:52 PM
Data refreshes hourly during market hours. Next update: 2:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRQR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 61 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 55 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 57 HOLD |
